Catalyst Wire Dossier Catalyst Wire Dossier

ipragliflozin

ipragliflozin · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for ipragliflozin, covering 2012-06-05 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin [Phase 3]

See pricing